▶ 調査レポート

遺伝病診断の世界市場(~2026年)

• 英文タイトル:Global Genetic Disease Diagnostic Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。遺伝病診断の世界市場(~2026年) / Global Genetic Disease Diagnostic Market Size, Status and Forecast 2020-2026 / MRC2-11QY12024資料のイメージです。• レポートコード:MRC2-11QY12024
• 出版社/出版日:QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、95ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:ヘルスケア
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料は遺伝病診断のグローバル市場について調査・分析したレポートです。種類別(出生前診断、遺伝子治療)市場規模、用途別(遺伝性疾患検査、薬理遺伝学的検査(PGx)、ヒト白血球抗原(HLA)検査、腫瘍検査)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別遺伝病診断の競争状況、市場シェア
・世界の遺伝病診断市場:種類別市場規模 2015年-2020年(出生前診断、遺伝子治療)
・世界の遺伝病診断市場:種類別市場規模予測 2021年-2026年(出生前診断、遺伝子治療)
・世界の遺伝病診断市場:用途別市場規模 2015年-2020年(遺伝性疾患検査、薬理遺伝学的検査(PGx)、ヒト白血球抗原(HLA)検査、腫瘍検査)
・世界の遺伝病診断市場:用途別市場規模予測 2021年-2026年(遺伝性疾患検査、薬理遺伝学的検査(PGx)、ヒト白血球抗原(HLA)検査、腫瘍検査)
・北米の遺伝病診断市場分析:米国、カナダ
・ヨーロッパの遺伝病診断市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの遺伝病診断市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の遺伝病診断市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの遺伝病診断市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Abbott、Celera Group、Elitech Group、PerkinElmer、Quest Diagnostics、AutoGenomics、Roche Diagnostics、BioRad、Transgenomic、Applied Biosystems
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Test the genetic disease. For example, color blindness, Down’ssyndrome, cystic fibrosis,etc
Rising incidences of genetic disorders that give rise to wide variety of independent diagnostic procedures globally is predominantly driving the growth of the global genetic disorder diagnostic market. Additionally, increasing awareness about prenatal diagnosis, rising attempt to improve patients quality of life and growing popularity of certain techniques such as gene therapy, medical genetics are further expected to boost market growth.

Market Analysis and Insights: Global Genetic Disease Diagnostic Market
The global Genetic Disease Diagnostic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Genetic Disease Diagnostic Scope and Market Size
Genetic Disease Diagnostic market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Genetic Disease Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Abbott
Celera Group
Elitech Group
PerkinElmer
Quest Diagnostics
AutoGenomics
Roche Diagnostics
BioRad
Transgenomic
Applied Biosystems

Market segment by Type, the product can be split into
Prenatal diagnosis
Gene therapy
Market segment by Application, split into
Inherited disorder testing
Pharmacogenetic testing (PGx)
Human leukocyte antigen (HLA) testing
Oncology testing

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Genetic Disease Diagnostic Revenue
1.4 Market by Type
1.4.1 Global Genetic Disease Diagnostic Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Prenatal diagnosis
1.4.3 Gene therapy
1.5 Market by Application
1.5.1 Global Genetic Disease Diagnostic Market Share by Application: 2020 VS 2026
1.5.2 Inherited disorder testing
1.5.3 Pharmacogenetic testing (PGx)
1.5.4 Human leukocyte antigen (HLA) testing
1.5.5 Oncology testing
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Genetic Disease Diagnostic Market Perspective (2015-2026)
2.2 Global Genetic Disease Diagnostic Growth Trends by Regions
2.2.1 Genetic Disease Diagnostic Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Genetic Disease Diagnostic Historic Market Share by Regions (2015-2020)
2.2.3 Genetic Disease Diagnostic Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Genetic Disease Diagnostic Market Growth Strategy
2.3.6 Primary Interviews with Key Genetic Disease Diagnostic Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Genetic Disease Diagnostic Players by Market Size
3.1.1 Global Top Genetic Disease Diagnostic Players by Revenue (2015-2020)
3.1.2 Global Genetic Disease Diagnostic Revenue Market Share by Players (2015-2020)
3.1.3 Global Genetic Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Genetic Disease Diagnostic Market Concentration Ratio
3.2.1 Global Genetic Disease Diagnostic Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Genetic Disease Diagnostic Revenue in 2019
3.3 Genetic Disease Diagnostic Key Players Head office and Area Served
3.4 Key Players Genetic Disease Diagnostic Product Solution and Service
3.5 Date of Enter into Genetic Disease Diagnostic Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Genetic Disease Diagnostic Historic Market Size by Type (2015-2020)
4.2 Global Genetic Disease Diagnostic Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Genetic Disease Diagnostic Market Size by Application (2015-2020)
5.2 Global Genetic Disease Diagnostic Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Genetic Disease Diagnostic Market Size (2015-2020)
6.2 Genetic Disease Diagnostic Key Players in North America (2019-2020)
6.3 North America Genetic Disease Diagnostic Market Size by Type (2015-2020)
6.4 North America Genetic Disease Diagnostic Market Size by Application (2015-2020)

7 Europe
7.1 Europe Genetic Disease Diagnostic Market Size (2015-2020)
7.2 Genetic Disease Diagnostic Key Players in Europe (2019-2020)
7.3 Europe Genetic Disease Diagnostic Market Size by Type (2015-2020)
7.4 Europe Genetic Disease Diagnostic Market Size by Application (2015-2020)

8 China
8.1 China Genetic Disease Diagnostic Market Size (2015-2020)
8.2 Genetic Disease Diagnostic Key Players in China (2019-2020)
8.3 China Genetic Disease Diagnostic Market Size by Type (2015-2020)
8.4 China Genetic Disease Diagnostic Market Size by Application (2015-2020)

9 Japan
9.1 Japan Genetic Disease Diagnostic Market Size (2015-2020)
9.2 Genetic Disease Diagnostic Key Players in Japan (2019-2020)
9.3 Japan Genetic Disease Diagnostic Market Size by Type (2015-2020)
9.4 Japan Genetic Disease Diagnostic Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Genetic Disease Diagnostic Market Size (2015-2020)
10.2 Genetic Disease Diagnostic Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Genetic Disease Diagnostic Market Size by Type (2015-2020)
10.4 Southeast Asia Genetic Disease Diagnostic Market Size by Application (2015-2020)

11 India
11.1 India Genetic Disease Diagnostic Market Size (2015-2020)
11.2 Genetic Disease Diagnostic Key Players in India (2019-2020)
11.3 India Genetic Disease Diagnostic Market Size by Type (2015-2020)
11.4 India Genetic Disease Diagnostic Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Genetic Disease Diagnostic Market Size (2015-2020)
12.2 Genetic Disease Diagnostic Key Players in Central & South America (2019-2020)
12.3 Central & South America Genetic Disease Diagnostic Market Size by Type (2015-2020)
12.4 Central & South America Genetic Disease Diagnostic Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Abbott
13.1.1 Abbott Company Details
13.1.2 Abbott Business Overview
13.1.3 Abbott Genetic Disease Diagnostic Introduction
13.1.4 Abbott Revenue in Genetic Disease Diagnostic Business (2015-2020))
13.1.5 Abbott Recent Development
13.2 Celera Group
13.2.1 Celera Group Company Details
13.2.2 Celera Group Business Overview
13.2.3 Celera Group Genetic Disease Diagnostic Introduction
13.2.4 Celera Group Revenue in Genetic Disease Diagnostic Business (2015-2020)
13.2.5 Celera Group Recent Development
13.3 Elitech Group
13.3.1 Elitech Group Company Details
13.3.2 Elitech Group Business Overview
13.3.3 Elitech Group Genetic Disease Diagnostic Introduction
13.3.4 Elitech Group Revenue in Genetic Disease Diagnostic Business (2015-2020)
13.3.5 Elitech Group Recent Development
13.4 PerkinElmer
13.4.1 PerkinElmer Company Details
13.4.2 PerkinElmer Business Overview
13.4.3 PerkinElmer Genetic Disease Diagnostic Introduction
13.4.4 PerkinElmer Revenue in Genetic Disease Diagnostic Business (2015-2020)
13.4.5 PerkinElmer Recent Development
13.5 Quest Diagnostics
13.5.1 Quest Diagnostics Company Details
13.5.2 Quest Diagnostics Business Overview
13.5.3 Quest Diagnostics Genetic Disease Diagnostic Introduction
13.5.4 Quest Diagnostics Revenue in Genetic Disease Diagnostic Business (2015-2020)
13.5.5 Quest Diagnostics Recent Development
13.6 AutoGenomics
13.6.1 AutoGenomics Company Details
13.6.2 AutoGenomics Business Overview
13.6.3 AutoGenomics Genetic Disease Diagnostic Introduction
13.6.4 AutoGenomics Revenue in Genetic Disease Diagnostic Business (2015-2020)
13.6.5 AutoGenomics Recent Development
13.7 Roche Diagnostics
13.7.1 Roche Diagnostics Company Details
13.7.2 Roche Diagnostics Business Overview
13.7.3 Roche Diagnostics Genetic Disease Diagnostic Introduction
13.7.4 Roche Diagnostics Revenue in Genetic Disease Diagnostic Business (2015-2020)
13.7.5 Roche Diagnostics Recent Development
13.8 BioRad
13.8.1 BioRad Company Details
13.8.2 BioRad Business Overview
13.8.3 BioRad Genetic Disease Diagnostic Introduction
13.8.4 BioRad Revenue in Genetic Disease Diagnostic Business (2015-2020)
13.8.5 BioRad Recent Development
13.9 Transgenomic
13.9.1 Transgenomic Company Details
13.9.2 Transgenomic Business Overview
13.9.3 Transgenomic Genetic Disease Diagnostic Introduction
13.9.4 Transgenomic Revenue in Genetic Disease Diagnostic Business (2015-2020)
13.9.5 Transgenomic Recent Development
13.10 Applied Biosystems
13.10.1 Applied Biosystems Company Details
13.10.2 Applied Biosystems Business Overview
13.10.3 Applied Biosystems Genetic Disease Diagnostic Introduction
13.10.4 Applied Biosystems Revenue in Genetic Disease Diagnostic Business (2015-2020)
13.10.5 Applied Biosystems Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Genetic Disease Diagnostic Key Market Segments
Table 2. Key Players Covered: Ranking by Genetic Disease Diagnostic Revenue
Table 3. Ranking of Global Top Genetic Disease Diagnostic Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Genetic Disease Diagnostic Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Prenatal diagnosis
Table 6. Key Players of Gene therapy
Table 7. Global Genetic Disease Diagnostic Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Genetic Disease Diagnostic Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Genetic Disease Diagnostic Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Genetic Disease Diagnostic Market Share by Regions (2015-2020)
Table 11. Global Genetic Disease Diagnostic Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Genetic Disease Diagnostic Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Genetic Disease Diagnostic Market Growth Strategy
Table 17. Main Points Interviewed from Key Genetic Disease Diagnostic Players
Table 18. Global Genetic Disease Diagnostic Revenue by Players (2015-2020) (Million US$)
Table 19. Global Genetic Disease Diagnostic Market Share by Players (2015-2020)
Table 20. Global Top Genetic Disease Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genetic Disease Diagnostic as of 2019)
Table 21. Global Genetic Disease Diagnostic by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Genetic Disease Diagnostic Product Solution and Service
Table 24. Date of Enter into Genetic Disease Diagnostic Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Genetic Disease Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 27. Global Genetic Disease Diagnostic Market Size Share by Type (2015-2020)
Table 28. Global Genetic Disease Diagnostic Revenue Market Share by Type (2021-2026)
Table 29. Global Genetic Disease Diagnostic Market Size Share by Application (2015-2020)
Table 30. Global Genetic Disease Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 31. Global Genetic Disease Diagnostic Market Size Share by Application (2021-2026)
Table 32. North America Key Players Genetic Disease Diagnostic Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Genetic Disease Diagnostic Market Share (2019-2020)
Table 34. North America Genetic Disease Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 35. North America Genetic Disease Diagnostic Market Share by Type (2015-2020)
Table 36. North America Genetic Disease Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 37. North America Genetic Disease Diagnostic Market Share by Application (2015-2020)
Table 38. Europe Key Players Genetic Disease Diagnostic Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Genetic Disease Diagnostic Market Share (2019-2020)
Table 40. Europe Genetic Disease Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Genetic Disease Diagnostic Market Share by Type (2015-2020)
Table 42. Europe Genetic Disease Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Genetic Disease Diagnostic Market Share by Application (2015-2020)
Table 44. China Key Players Genetic Disease Diagnostic Revenue (2019-2020) (Million US$)
Table 45. China Key Players Genetic Disease Diagnostic Market Share (2019-2020)
Table 46. China Genetic Disease Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 47. China Genetic Disease Diagnostic Market Share by Type (2015-2020)
Table 48. China Genetic Disease Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 49. China Genetic Disease Diagnostic Market Share by Application (2015-2020)
Table 50. Japan Key Players Genetic Disease Diagnostic Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Genetic Disease Diagnostic Market Share (2019-2020)
Table 52. Japan Genetic Disease Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Genetic Disease Diagnostic Market Share by Type (2015-2020)
Table 54. Japan Genetic Disease Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Genetic Disease Diagnostic Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Genetic Disease Diagnostic Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Genetic Disease Diagnostic Market Share (2019-2020)
Table 58. Southeast Asia Genetic Disease Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Genetic Disease Diagnostic Market Share by Type (2015-2020)
Table 60. Southeast Asia Genetic Disease Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Genetic Disease Diagnostic Market Share by Application (2015-2020)
Table 62. India Key Players Genetic Disease Diagnostic Revenue (2019-2020) (Million US$)
Table 63. India Key Players Genetic Disease Diagnostic Market Share (2019-2020)
Table 64. India Genetic Disease Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 65. India Genetic Disease Diagnostic Market Share by Type (2015-2020)
Table 66. India Genetic Disease Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 67. India Genetic Disease Diagnostic Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Genetic Disease Diagnostic Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Genetic Disease Diagnostic Market Share (2019-2020)
Table 70. Central & South America Genetic Disease Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Genetic Disease Diagnostic Market Share by Type (2015-2020)
Table 72. Central & South America Genetic Disease Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Genetic Disease Diagnostic Market Share by Application (2015-2020)
Table 74. Abbott Company Details
Table 75. Abbott Business Overview
Table 76. Abbott Product
Table 77. Abbott Revenue in Genetic Disease Diagnostic Business (2015-2020) (Million US$)
Table 78. Abbott Recent Development
Table 79. Celera Group Company Details
Table 80. Celera Group Business Overview
Table 81. Celera Group Product
Table 82. Celera Group Revenue in Genetic Disease Diagnostic Business (2015-2020) (Million US$)
Table 83. Celera Group Recent Development
Table 84. Elitech Group Company Details
Table 85. Elitech Group Business Overview
Table 86. Elitech Group Product
Table 87. Elitech Group Revenue in Genetic Disease Diagnostic Business (2015-2020) (Million US$)
Table 88. Elitech Group Recent Development
Table 89. PerkinElmer Company Details
Table 90. PerkinElmer Business Overview
Table 91. PerkinElmer Product
Table 92. PerkinElmer Revenue in Genetic Disease Diagnostic Business (2015-2020) (Million US$)
Table 93. PerkinElmer Recent Development
Table 94. Quest Diagnostics Company Details
Table 95. Quest Diagnostics Business Overview
Table 96. Quest Diagnostics Product
Table 97. Quest Diagnostics Revenue in Genetic Disease Diagnostic Business (2015-2020) (Million US$)
Table 98. Quest Diagnostics Recent Development
Table 99. AutoGenomics Company Details
Table 100. AutoGenomics Business Overview
Table 101. AutoGenomics Product
Table 102. AutoGenomics Revenue in Genetic Disease Diagnostic Business (2015-2020) (Million US$)
Table 103. AutoGenomics Recent Development
Table 104. Roche Diagnostics Company Details
Table 105. Roche Diagnostics Business Overview
Table 106. Roche Diagnostics Product
Table 107. Roche Diagnostics Revenue in Genetic Disease Diagnostic Business (2015-2020) (Million US$)
Table 108. Roche Diagnostics Recent Development
Table 109. BioRad Business Overview
Table 110. BioRad Product
Table 111. BioRad Company Details
Table 112. BioRad Revenue in Genetic Disease Diagnostic Business (2015-2020) (Million US$)
Table 113. BioRad Recent Development
Table 114. Transgenomic Company Details
Table 115. Transgenomic Business Overview
Table 116. Transgenomic Product
Table 117. Transgenomic Revenue in Genetic Disease Diagnostic Business (2015-2020) (Million US$)
Table 118. Transgenomic Recent Development
Table 119. Applied Biosystems Company Details
Table 120. Applied Biosystems Business Overview
Table 121. Applied Biosystems Product
Table 122. Applied Biosystems Revenue in Genetic Disease Diagnostic Business (2015-2020) (Million US$)
Table 123. Applied Biosystems Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Genetic Disease Diagnostic Market Share by Type: 2020 VS 2026
Figure 2. Prenatal diagnosis Features
Figure 3. Gene therapy Features
Figure 4. Global Genetic Disease Diagnostic Market Share by Application: 2020 VS 2026
Figure 5. Inherited disorder testing Case Studies
Figure 6. Pharmacogenetic testing (PGx) Case Studies
Figure 7. Human leukocyte antigen (HLA) testing Case Studies
Figure 8. Oncology testing Case Studies
Figure 9. Genetic Disease Diagnostic Report Years Considered
Figure 10. Global Genetic Disease Diagnostic Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Genetic Disease Diagnostic Market Share by Regions: 2020 VS 2026
Figure 12. Global Genetic Disease Diagnostic Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Genetic Disease Diagnostic Market Share by Players in 2019
Figure 15. Global Top Genetic Disease Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genetic Disease Diagnostic as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Genetic Disease Diagnostic Revenue in 2019
Figure 17. North America Genetic Disease Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Genetic Disease Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Genetic Disease Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Genetic Disease Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Genetic Disease Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Genetic Disease Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Genetic Disease Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed